Literature DB >> 26984717

Native T1 Relaxation Time and Extracellular Volume Fraction as Accurate Markers of Diffuse Myocardial Fibrosis in Heart Valve Disease - Comparison With Targeted Left Ventricular Myocardial Biopsy.

Radka Kockova1, Petr Kacer, Jan Pirk, Jiri Maly, Lucie Sukupova, Viktor Sikula, Martin Kotrc, Lucia Barciakova, Eva Honsova, Marek Maly, Josef Kautzner, David Sedmera, Martin Penicka.   

Abstract

BACKGROUND: The aim of our study was to investigate the relationship between the cardiac magnetic resonance (CMR)-derived native T1 relaxation time and myocardial extracellular volume (ECV) fraction and the extent of diffuse myocardial fibrosis (DMF) on targeted myocardial left ventricular (LV) biopsy. METHODS AND 
RESULTS: The study population consisted of 40 patients (age 63±8 years, 65% male) undergoing valve and/or ascending aorta surgery for severe aortic stenosis (77.5%), root dilatation (7.5%) or valve regurgitation (15%). The T1 relaxation time was assessed in the basal interventricular septum pre- and 10-min post-contrast administration using the modified Look-Locker Inversion recovery sequence prior to surgery. LV myocardial biopsy specimen was obtained during surgery from the basal interventricular septal segment matched with the T1 mapping assessment. The percentage of myocardial collagen was quantified using picrosirius red staining. The average percentage of myocardial collagen was 22.0±14.8%. Both native T1 relaxation time with cutoff value ≥1,010 ms (sensitivity=90%, specificity=73%, area under the curve=0.82) and ECV with cutoff value ≥0.32 (sensitivity=80%, specificity=90%, area under the curve=0.85) showed high accuracy to identify severe (>30%) DMF. The native T1 relaxation time showed significant correlation with LV mass (P<0.01).
CONCLUSIONS: Native T1 relaxation time and ECV at 10 min after contrast administration are accurate markers of DMF. (Circ J 2016; 80: 1202-1209).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26984717     DOI: 10.1253/circj.CJ-15-1309

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  12 in total

1.  Right Ventricular Fibrosis Is Related to Pulmonary Artery Stiffness in Pulmonary Hypertension: A Cardiac Magnetic Resonance Imaging Study.

Authors:  Matthew Jankowich; Siddique A Abbasi; Alexander Vang; Gaurav Choudhary
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

2.  4D flow MRI, cardiac function, and T1 -mapping: Association of valve-mediated changes in aortic hemodynamics with left ventricular remodeling.

Authors:  Julia Geiger; Amir A Rahsepar; Kenichiro Suwa; Alex Powell; Ahmadreza Ghasemiesfe; Alex J Barker; Jeremy D Collins; James C Carr; Michael Markl
Journal:  J Magn Reson Imaging       Date:  2017-12-05       Impact factor: 4.813

Review 3.  Multimodality imaging assessment of mitral valve anatomy in planning for mitral valve repair in secondary mitral regurgitation.

Authors:  Romain Capoulade; Nicolas Piriou; Jean-Michel Serfaty; Thierry Le Tourneau
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

4.  T1 mapping and feature tracking imaging of left ventricular extracellular remodeling in severe aortic stenosis.

Authors:  Xiaoyu Wei; Xuhua Jian; Jiajun Xie; Rui Chen; Xiaodan Li; Zhicheng Du; Xiaomei Zhong; Jinglei Li; Xiaobing Zhou; Guanmin Ren; Yingjie Mei; Hui Liu
Journal:  Cardiovasc Diagn Ther       Date:  2020-12

Review 5.  Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.

Authors:  Tong Liu; Deli Song; Jianzeng Dong; Pinghui Zhu; Jie Liu; Wei Liu; Xiaohai Ma; Lei Zhao; Shukuan Ling
Journal:  Front Physiol       Date:  2017-04-24       Impact factor: 4.566

Review 6.  Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis.

Authors:  Rong Bing; João L Cavalcante; Russell J Everett; Marie-Annick Clavel; David E Newby; Marc R Dweck
Journal:  JACC Cardiovasc Imaging       Date:  2019-02

7.  New Imaging Markers of Clinical Outcome in Asymptomatic Patients with Severe Aortic Regurgitation.

Authors:  Radka Kočková; Hana Línková; Zuzana Hlubocká; Alena Pravečková; Andrea Polednová; Lucie Súkupová; Martin Bláha; Jiří Malý; Eva Honsová; David Sedmera; Martin Pěnička
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

8.  Prognostic value of myocardial fibrosis in severe aortic stenosis: study protocol for a prospective observational multi-center study (FIB-AS).

Authors:  Giedrė Balčiūnaitė; Darius Palionis; Edvardas Žurauskas; Viktor Skorniakov; Vilius Janušauskas; Aleksejus Zorinas; Tomas Zaremba; Nomeda Valevičienė; Audrius Aidietis; Pranas Šerpytis; Kęstutis Ručinskas; Peter Sogaard; Sigita Glaveckaitė
Journal:  BMC Cardiovasc Disord       Date:  2020-06-08       Impact factor: 2.298

9.  Extracellular Myocardial Volume in Patients With Aortic Stenosis.

Authors:  Russell J Everett; Thomas A Treibel; Miho Fukui; Heesun Lee; Marzia Rigolli; Anvesha Singh; Petra Bijsterveld; Lionel Tastet; Tarique Al Musa; Laura Dobson; Calvin Chin; Gabriella Captur; Sang Yong Om; Stephanie Wiesemann; Vanessa M Ferreira; Stefan K Piechnik; Jeanette Schulz-Menger; Erik B Schelbert; Marie-Annick Clavel; David E Newby; Saul G Myerson; Phillipe Pibarot; Sahmin Lee; João L Cavalcante; Seung-Pyo Lee; Gerry P McCann; John P Greenwood; James C Moon; Marc R Dweck
Journal:  J Am Coll Cardiol       Date:  2020-01-28       Impact factor: 24.094

Review 10.  Advanced cardiovascular multimodal imaging and aortic stenosis.

Authors:  Carmen Cionca; Alexandru Zlibut; Lucia Agoston-Coldea; Teodora Mocan
Journal:  Heart Fail Rev       Date:  2021-07-19       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.